Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: Promise for clinical application
Author:
Funder
Ministry of Education, Culture, Sports, Science and Technology, Japan
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference41 articles.
1. Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model;Abu-Lila;J. Control. Release,2009
2. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model;Abu Lila;J. Control. Release,2009
3. Oxaliplatin: a review in the era of molecularly targeted therapy;Alcindor;Curr. Oncol.,2011
4. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol);Allen;Biosci. Rep.,2002
5. Colorimetric assay methods for free and phosphorylated glyceric acids;Bartlett;J. Biol. Chem.,1959
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes;Biological and Pharmaceutical Bulletin;2024-02-20
2. Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives;Journal of Pharmaceutical Sciences;2023-11
3. Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats;Molecular Pharmaceutics;2023-08-07
4. PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective;Bioconjugate Chemistry;2023-05-10
5. Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin;Current Cancer Drug Targets;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3